Risankizumab and guselkumab for psoriasis: a 1-year real-world practice indirect comparison by Leyla Baykal Selçuk, Hande Ermiş Akkuş, Burak Akşan, Deniz Aksu Arıca

Subjects: Get full text

The use of guselkumab in psoriatic arthritis: evidence from real clinical practice by N. V. Nekrasova, Yu. E. Borovikov, T. G. Zadorkina, P. V. Nekrasova

Subjects: Get full text

Prospects for the use of monoclonal antibodies to interleukin 23 Gusеlkumab in psoriatic arthritis: New data by E. L. Nasonov, T. V. Korotaeva, S. Rodolfi, C. F. Selmi

Subjects: Get full text

Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States by Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, Lilian Diaz, Patrick Lefebvre, Steven R. Feldman

Subjects: Get full text

Successful Guselkumab Treatment in a Patient with Comorbid Psoriasis and Amyotrophic Lateral Sclerosis: A Case Study and Literature Review by Xiong J, Chen X, Huang K, Pan Y

Subjects: Get full text

Off-label dermatologic uses of IL-23 inhibitors by Justin Porter, Lacey Zimmerman, Melissa Nickles, Sheryl Hoyer

Subjects: Get full text

A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 Weeks by Suzy van Sanden, Agata Schubert, Barkha P. Patel, Miriam Zimmermann, Fareen Hassan

Subjects: Get full text

Experience of guselkumab usage in the treatment of patients with psoriatic arthritis in real clinical practice by E. Yu. Loginova, Yu. L. Korsakova, T. V. Korotaeva

Subjects: Get full text

Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004–2023) by Yingdong Wang, Junchen Li, Chenqi Guo, Guojing Yang, Haiyue Lin, Yu Zhang

Subjects: Get full text

Successful treatment of generalized pustular psoriasis with guselkumab by Martina Part

Subjects: Get full text

Positioning Guselkumab in The Treatment Algorithm of Patients with Crohn’s Disease by D'Amico F, Bencardino S, Magro F, Dignass A, Gutiérrez Casbas A, Verstockt B, Hart A, Armuzzi A, Peyrin-Biroulet L, Danese S

Subjects: “…guselkumab…”
Get full text

Interleukin-23p19 inhibitors for the treatment of moderate-to-severe psoriasis: an expert opinion of real-world evidence studies in Europe by S. Ständer, D. Thaçi

Subjects: Get full text

Successful treatment of pyoderma gangrenosum with guselkumab by Sofia Botvid, Claus Zachariae, Lone Skov, Jakob Ferløv Schwensen

Subjects: Get full text

Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study by Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli, Matteo Megna, Annunziata Raimondo, Giacomo Caldarola, Nicoletta Bernardini, Anna Balato, Anna Campanati, Maria Esposito, Claudio Bonifati, Viviana Lora, Luca Potestio, Serena Lembo, Francesco Loconsole, Eleonora De Luca, Nevena Skroza, Dario Buononato, Tommaso Bianchelli, Maria Concetta Fargnoli, Nello Tommasino, Felice Primavera, Clara De Simone, Luca Bianchi, Marco Galluzzo

Subjects: “…Guselkumab…”
Get full text

Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA–IL PSO (Italian Landscape... by Mario Valenti, Luciano Ibba, Sara Di Giulio, Paolo Dapavo, Piergiorgio Malagoli, Angelo V. Marzano, Francesco Loconsole, Martina Burlando, Anna Balato, Valentina Dini, Matteo Megna, Giampiero Girolomoni, Emanuele Trovato, Claudia Lasagni, Massimo Travaglini, Claudio Guarneri, Nicola Zerbinati, Simone Ribero, Francesca M. Gaiani, Carlo G. Carrera, Emanuele C. Cozzani, Eugenia V. Di Brizzi, Alessandra Michelucci, Luca Potestio, Martina Maurelli, Martina Dragotto, Luca Mastorino, Eleonora Bongiovanni, Francesco Messina, Andrea Sechi, Rossana Moroni, Antonio Costanzo, Alessandra Narcisi

Subjects: Get full text

Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling by Giulia Valdiserra, Clelia Di Salvo, Matteo Fornai, Luca Antonioli

Subjects: Get full text

IL-23 inhibitor treatment of immune checkpoint inhibitor-associated psoriasis: Case series and review of literature by Natalie Bourand, MS, Drew Kuraitis, MD, PhD, Bethany Lema, MD, Susan Pei, MD

Subjects: Get full text